
Academic Journal
Q1JBMR Plus
About JBMR Plus
JBMR Plus is a scholarly journal published by Oxford University Press. SCImago 2025 lists it in Q1, with an SJR of 1.007 and H-index of 43.
Coverage: 2017-2026. Research categories: Orthopedics and Sports Medicine (Q1); Endocrinology, Diabetes and Metabolism (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-05-02. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Bone health and osteoporosis research; Bone health and treatments; Bone Metabolism and Diseases; Parathyroid Disorders and Treatments; Bone and Joint Diseases; Connective tissue disorders research.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Bone quality deterioration is accompanied by mesenchymal stem cell defects in osteoporosis patients undergoing spinal fusion
Fen Xie, Bin Zhou, Yuling Liu, Jian Wang et al.
2026-09-30 · DOI: 10.1093/jbmrpl/ziag161Leg Muscle Assessment by HR-pQCT and DXA: Associations Between Imaging Measures and Muscle Function in Adults with Obesity – A Pilot Study
Søren Gam, Joshua R Stapleton, Vivian Jing, Eric Zeng et al.
2026-09-22 · DOI: 10.1093/jbmrpl/ziag158New Trabecular Bone Score Reference Values for Children and Adolescents According to Age and Sex and Their Relationship with Body Size and Fracture Incidence
David R Weber, Halley M Wasserman, Guillame Gatineau, Heidi Kalkwarf et al.
2026-09-21 · DOI: 10.1093/jbmrpl/ziag159Intracranial Phosphaturic Mesenchymal Tumor Mimicking Meningioma and Causing Tumor-Induced Osteomalacia: A Case Report
Samaneh Rabiei, Daniel Collins, Paul Schwartz, Antonella Pallante et al.
2026-09-17 · DOI: 10.1093/jbmrpl/ziag156Involvement of reduced ENPP1 function in the pathogenesis of ossification of the posterior longitudinal ligament
Soichiro Kimura, Koichiro Furukawa, Koki Irie, Natsuho Adachi et al.
2026-09-30 · DOI: 10.1093/jbmrpl/ziag157Burosumab as bridging therapy in autosomal dominant hypophosphatemic rickets with femoral fracture nonunion and iron deficiency
Matej Rakusa, Tomaz Kocjan
2026-09-30 · DOI: 10.1093/jbmrpl/ziag151Measures of mortality among people living with fibrodysplasia ossificans progressiva in the United States, 2017–2023
Alexander Breskin, Victor O Popoola, Michelle Davis, Sammi Kile et al.
2026-09-15 · DOI: 10.1093/jbmrpl/ziag154Cortical Indices, DXA, and FRAX as Indicators of Bone Fragility: A Comparative Human Cadaveric Study
Anthony J Yosick, Sophia L Turbide, Andrew J Berger, Hani A Awad et al.
2026-09-14 · DOI: 10.1093/jbmrpl/ziag155A novel mouse trauma model for osteonecrosis of the femoral head
Zeynep Bal, Yukika Tanabe, Fitriana Nur Rahmawati, Man Wang et al.
2026-09-11 · DOI: 10.1093/jbmrpl/ziag135Greater D3-creatine muscle mass and MRI thigh muscle volume are associated with higher bone strength in older adults: exploratory findings in The Study of Muscle, Mobility and Aging (SOMMA)
Nina Z Heilmann, Kerri S Freeland, Lauren S Roe, Nicole M Sekel et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag113Skeletal and body composition effects of orchiectomy in a colony of diet-induced obese cynomolgus macaques
Melissa A Kirigiti, Lindsay Bader, Cicely Zaro, Casey M McGuire et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag150Dissecting Hypoxia Inducible Factor-Driven High Bone Mass Phenotype in Mice Lacking Osteocytic Von Hippel-Lindau
Adriana P Pantoja, Sarah V Mendoza, Deepa K Murugesh, Blaine A Christiansen et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag148Is direct oxidative damage of bone collagen associated with poor human cortical bone tissue fracture resistance?
Daniel Y Dapaah, Shoutaro Arakawa, Gwennyth A Carroll, Yiran Wang et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag152Identification of candidate receptors mediating the osteoanabolic influence of Wnt1
Kim M Walter, Leon Grahn, Wenbo Zhao, Kenneth Schöneck et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag153Palovarotene impact on fibrodysplasia ossificans progressiva (FOP): data from month 48 of the phase III MOVE trial
Robert J Pignolo, Edward C Hsiao, Mona Al Mukaddam, Geneviève Baujat et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag141BCX9250 is a potent small-molecule inhibitor of Activin A Receptor Type 1 (ACVR1/ALK2) for fibrodysplasia ossificans progressiva
Haitao Wang, Saman Toutounchi, Robert J Pignolo, Xiaogang Cheng et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag145Repeated romosozumab with short-term ibandronate sequencing in high-risk osteoporosis: a retrospective single-center cohort study
Hiroyuki Maeda, Takahiro Maeda, Mutsuhiro Maeda
2026-08-30 · DOI: 10.1093/jbmrpl/ziag149Phenotypic spectrum and quality of life in pediatric Bruck syndrome due to FKBP10 and PLOD2 variants: a 2-center United Arab Emirates experience
Mohammad Hosny Awad, Rania Eladl, Asmahan Tagelsir Abdalla, Ibrar Majid et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag146Creation and characterization of novel knock-in mouse models of hypophosphatasia
Rena Okawa, Marin Ochiai, Hiroshi Kurosaka, Tamami Kadota et al.
2026-08-30 · DOI: 10.1093/jbmrpl/ziag14710th International Conference on Osteoimmunology: Interactions of the Immune and Skeletal Systems
2026-08-25 · DOI: 10.1093/jbmrpl/ziag134Reviews
Community Reviews
Version History
October 4, 2026 at 8:59 pm
October 2, 2026